SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Takeaki Ishii, Akio Sakamoto, Shuichi Matsuda, Yoshihiro Matsumoto, Katsumi Harimaya, Yusuke Takahashi, Yoshinao Oda, Yukihide Iwamoto, Leiomyosarcoma in the humerus with leukocytosis and elevation of serum G-CSF, Skeletal Radiology, 2011, 41, 6, 719

    CrossRef

  2. 2
    G. F. G. Almeida, G. Castro, I. M. L. Snitcovsky, S. A. Siqueira, E. H. Akaishi, O. P. Camargo, C. R. G. C. M. Oliveira, M. H. H. Federico, Sequential Dose-Dense Doxorubicin and Ifosfamide in Advanced Soft-Tissue Sarcoma Patients in an Out-Patient-Basis Schedule, Sarcoma, 2011, 2011, 1

    CrossRef

  3. You have free access to this content3
    Tariq Tajuddin, Elizabeth J Ryan, Suzanne Norris, John E Hegarty, Cliona O'Farrelly, Interferon-α suppressed granulocyte colony stimulating factor production is reversed by CL097, a TLR7/8 agonist, Journal of Gastroenterology and Hepatology, 2010, 25, 12
  4. 4
    Clifford Liongue, Craig Wright, Aaron P. Russell, Alister C. Ward, Granulocyte colony-stimulating factor receptor: Stimulating granulopoiesis and much more, The International Journal of Biochemistry & Cell Biology, 2009, 41, 12, 2372

    CrossRef

  5. 5
    John R. Wingard, Mohamed Elmongy, Strategies for minimizing complications of neutropenia: Prophylactic myeloid growth factors or antibiotics, Critical Reviews in Oncology/Hematology, 2009, 72, 2, 144

    CrossRef

  6. 6
    Scott Marshall McCloskey, Philip Windrum, Mary Frances McMullin, Brian Walker, Alexandra E. Irvine, G-CSF increases proteasome activity in myeloid cells, British Journal of Haematology, 2008, 143, 4
  7. 7
    Pete Anderson, Lisa Kopp, Nicholas Anderson, Kathleen Cornelius, Cynthia Herzog, Dennis Hughes, Winston Huh, Novel bone cancer drugs: investigational agents and control paradigms for primary bone sarcomas (Ewing's sarcoma and osteosarcoma), Expert Opinion on Investigational Drugs, 2008, 17, 11, 1703

    CrossRef